Echelon Wealth Partners analyst Stefan Quenneville maintained a Buy rating on Nanalysis Scientific (NSCIF - Research Report) yesterday and set a price target of C$2.75. The company's shares closed yesterday at $0.57.According to TipRanks, Quenneville is an analyst with an average return of -26.2% and a 19.12% success rate. Quenneville covers the Healthcare sector, focusing on stocks such as Nanalysis Scientific, Antibe Therapeutics, and Cognetivity Neurosciences.Nanalysis Scientific has an analyst consensus of Moderate Buy, with a price target consensus of $2.02.See the top stocks recommended by analysts >>The company has a one-year high of $1.23 and a one-year low of $0.46. Currently, Nanalysis Scientific has an average volume of 66.58K.
https://www.tipranks.com/news/blurbs/echelon-wealth-partners-sticks-to-its-buy-rating-for-nanalysis-scientific-nscif?utm_source=advfn.com&utm_medium=referral